Regulatory Developments July 2020

05_NEW_Reg_Dev.jpg

Learn about recent draft guidances, such as considerations for pre-investigational new drug application meeting requests for Covid-19 related drugs as well discussions among the Division of Antiviral Products.

Data collected as of June 23, 2020.

Table of Contents
Regulatory Developments
July 2020

Related Stories